06 Apr 2009 06:00 AM
New OCT Applications From Carl Zeiss Meditec Support Full Spectrum Of Cataract, Refractive, Glaucoma And Retina Procedures
Advanced new optical coherence tomography (OCT) applications will be showcased this week at the American Society of Cataract and Refractive Surgery (ASCRS) meeting in San Francisco by Carl Zeiss Meditec, a leader in complete ophthalmic systems, including IOLs and disposables. The New Technology area of booth 1926 will highlight the new suite of OCT innovations along with a first-ever cinematic showing of high-definition images that have been created using 3D rendering techniques by Dr. Carl Glittenberg of Austria.
"Since we first introduced OCT technology to the ophthalmic industry nearly fifteen years ago, we have continued to invest in applications that leverage clinical and scientific advances in the field as well as features that make the technology itself more efficient and user-friendly for practitioners," said Michael Kaschke, President and Chief Executive Officer of Carl Zeiss Meditec.
New OCT Applications
The newest version of Cirrus HD-OCT 4.0 adds critical features to support cataract and refractive surgeons as well as advanced analyses for tracking change in glaucoma and managing retina disease. Cirrus 4.0 software has been released internationally and is pending FDA clearance in the US.
-Anterior Segment Imaging provides visualization of the cornea and angle with central corneal thickness measurement for glaucoma management. No external lenses are needed.
-Normative RNFL and Macular Thickness Data allows physicians to identify pre-existing glaucoma and retinal disease and to rule-out suspected glaucoma.
-Guided Progression Analysis ™ (GPA) software supports glaucoma treatment decision making by identifying statistically significant RNFL thickness changes.
-Macular Change Analysis helps physicians evaluate retinal status and response to therapy by mapping changes in macular thickness measurements.
Cirrus HD-OCT 4.0 is ideal for practices that rely on advanced technologies to identify pre-existing eye diseases, to closely monitor disease progression and to determine the most appropriate course of treatment for each patient. The new software technologies can be seamlessly integrated onto any Cirrus HD-OCT platform.
"Cirrus is a valuable tool in my practice for both my cataract/refractive surgery and glaucoma patients," said Ike K. Ahmed, MD, FRCSC, Assistant Professor at the University of Toronto and Clinical Assistant Professor at the University of Utah in Salt Lake City. "It helps me to identify potential problems in my pre-operative cataract/refractive workups and my patients more easily understand what they can expect post-operatively."
Dynamic new features for Stratus OCT, the most widely adopted OCT platform worldwide, are also now available for the first time at ASCRS 2009…
"Since we first introduced OCT technology to the ophthalmic industry nearly fifteen years ago, we have continued to invest in applications that leverage clinical and scientific advances in the field as well as features that make the technology itself more efficient and user-friendly for practitioners," said Michael Kaschke, President and Chief Executive Officer of Carl Zeiss Meditec.
New OCT Applications
The newest version of Cirrus HD-OCT 4.0 adds critical features to support cataract and refractive surgeons as well as advanced analyses for tracking change in glaucoma and managing retina disease. Cirrus 4.0 software has been released internationally and is pending FDA clearance in the US.
-Anterior Segment Imaging provides visualization of the cornea and angle with central corneal thickness measurement for glaucoma management. No external lenses are needed.
-Normative RNFL and Macular Thickness Data allows physicians to identify pre-existing glaucoma and retinal disease and to rule-out suspected glaucoma.
-Guided Progression Analysis ™ (GPA) software supports glaucoma treatment decision making by identifying statistically significant RNFL thickness changes.
-Macular Change Analysis helps physicians evaluate retinal status and response to therapy by mapping changes in macular thickness measurements.
Cirrus HD-OCT 4.0 is ideal for practices that rely on advanced technologies to identify pre-existing eye diseases, to closely monitor disease progression and to determine the most appropriate course of treatment for each patient. The new software technologies can be seamlessly integrated onto any Cirrus HD-OCT platform.
"Cirrus is a valuable tool in my practice for both my cataract/refractive surgery and glaucoma patients," said Ike K. Ahmed, MD, FRCSC, Assistant Professor at the University of Toronto and Clinical Assistant Professor at the University of Utah in Salt Lake City. "It helps me to identify potential problems in my pre-operative cataract/refractive workups and my patients more easily understand what they can expect post-operatively."
Dynamic new features for Stratus OCT, the most widely adopted OCT platform worldwide, are also now available for the first time at ASCRS 2009…
